ZOMDF · Zomedica Corp.
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $34.33M | $32.03M | $27.29M | $25.19M | $18.93M | $4.13M | $0 | — | — | — | — | |
| — | — | — | — | $2.7M | $357K | — | — | — | — | — | |
| $11.57M | $10.35M | $8.2M | $7.87M | $5.46M | $1.08M | $0 | — | — | — | — | |
| $22.76M | $21.68M | $19.09M | $17.32M | $13.47M | $3.05M | $0 | — | — | — | — | |
| — | 67.68% | 69.95% | 68.76% | 71.15% | 73.89% | — | — | — | — | — | |
| $6.47M | $7.17M | $7.27M | $5.74M | $2.58M | $1.67M | $8.04M | $10.35M | $10.32M | $2.75M | $1.52M | |
| $17.35M | $18.54M | $17.19M | $14.14M | $9.88M | — | — | — | — | — | — | |
| $23.65M | $24.5M | $29.66M | $29.03M | $22.93M | — | $6.01M | $6.99M | $4.52M | $3.95M | $2.92M | |
| $38.09M | — | — | — | $33M | $22.76M | $8.72M | — | — | — | — | |
| $1.37M | $5.9M | $6.44M | $5.47M | $3.62M | $874K | $224.11K | $1082 | $2083 | $2797 | $2690 | |
| — | — | — | — | — | — | $305.91K | $277.15K | $203.68K | $89.61K | $43.13K | |
| -$24.71M | -$84.35M | -$51.05M | -$43.28M | -$21.92M | -$21.37M | -$16.76M | -$19.78M | -$16.58M | -$8.08M | -$5.73M | |
| — | -263.36% | -187.11% | -171.82% | -115.81% | -517.14% | — | — | — | — | — | |
| — | — | — | — | — | — | -$16.46M | -$19.51M | -$16.38M | -$7.99M | -$5.68M | |
| — | — | — | $50K | $1000 | $6000 | $732 | $18.34K | — | — | — | |
| -$126K | -$144K | $10K | $2.08M | -$7000 | $52K | — | — | — | — | — | |
| — | -$141K | -$159K | — | — | — | — | — | — | — | — | |
| -$22.77M | -$82.14M | -$47.54M | -$35.86M | -$19.38M | -$20.72M | -$16.91M | -$19.78M | -$16.65M | -$8.07M | -$5.74M | |
| -$182K | -$278K | -$557K | -$1.33M | -$2.37M | -$2.33M | $0 | — | — | — | — | |
| -$22.58M | -$81.86M | -$46.98M | -$34.53M | -$17.02M | -$18.38M | -$16.91M | -$19.78M | -$16.65M | -$8.07M | -$5.74M | |
| — | -255.57% | -172.19% | -137.1% | -89.88% | -444.8% | — | — | — | — | — | |
| -$22.61M | -$81.79M | -$46.94M | -$33.64M | -$17.86M | -$18.38M | -$16.91M | — | — | — | — | |
| USD/shares | — | -$0.08 | -$0.05 | -$0.04 | -$0.02 | — | — | — | — | — | — |
| USD/shares | — | -$0.08 | -$0.05 | -$0.04 | -$0.02 | — | — | — | — | — | — |
| shares | — | 979.95M | 979.95M | 979.95M | 979.95M | 956.53M | 364.44M | 106.3M | 93.44M | 87.4M | 80.16M |
| shares | — | 979.95M | 979.95M | 979.95M | 979.95M | 956.53M | 364.44M | 106.3M | 93.44M | 87.4M | 80.16M |
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 75 similar-size Medical Devices companies (of 145 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Therapeutics | $26,197,000 | $24,852,000 | $23,809,000 | $18,539,000 | $4,008,000 |
| Development Services | $3,032,000 | — | — | — | — |
| Diagnostics | $2,801,000 | $2,433,000 | $1,377,000 | $391,000 | $125,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| United States | $26,461,000 | $22,556,000 | $20,682,000 |
| Non Us | $5,569,000 | $4,729,000 | $4,504,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Consumables Revenue | $20,678,000 | $17,663,000 | $16,313,000 | $11,456,000 | $125,000 |
| Capital Revenue | $9,253,000 | $9,491,000 | $8,788,000 | $7,338,000 | — |
| Engineering Revenue | $1,976,000 | — | — | — | — |
| Product And Service Other | $123,000 | $131,000 | $85,000 | $136,000 | $142,000 |
| Instruments Revenue | — | — | — | — | $1,793,000 |
| Trodes Revenue | — | — | — | — | $2,073,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2021 |
|---|---|
| Net Assets | -$21,367,997 |